Title of article
Exploiting pluripotent stem cell technology for drug discovery, screening, safety, and toxicology assessments
Author/Authors
McGivern، نويسنده , , Jered V. and Ebert، نويسنده , , Allison D.، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2014
Pages
9
From page
170
To page
178
Abstract
In order for the pharmaceutical industry to maintain a constant flow of novel drugs and therapeutics into the clinic, compounds must be thoroughly validated for safety and efficacy in multiple biological and biochemical systems. Pluripotent stem cells, because of their ability to develop into any cell type in the body and recapitulate human disease, may be an important cellular system to add to the drug development repertoire. This review will discuss some of the benefits of using pluripotent stem cells for drug discovery and safety studies as well as some of the recent applications of stem cells in drug screening studies. We will also address some of the hurdles that need to be overcome in order to make stem cell-based approaches an efficient and effective tool in the quest to produce clinically successful drug compounds.
Keywords
Hepatotoxicity , cardiotoxicity , High content screening , Embryonic stem cells , Induced Pluripotent Stem Cells , High throughput screening , disease modeling
Journal title
Advanced Drug Delivery Reviews
Serial Year
2014
Journal title
Advanced Drug Delivery Reviews
Record number
1763990
Link To Document